TY - JOUR
T1 - Development of Plasmodium-specific liver-resident memory CD8+ T cells after heat-killed sporozoite immunization in mice
AU - Ghilas, Sonia
AU - Enders, Matthias H.
AU - May, Rose
AU - Holz, Lauren E.
AU - Fernandez-Ruiz, Daniel
AU - Cozijnsen, Anton
AU - Mollard, Vanessa
AU - Cockburn, Ian A.
AU - McFadden, Geoffrey I.
AU - Heath, William R.
AU - Beattie, Lynette
N1 - Publisher Copyright:
© 2021 Wiley-VCH GmbH
PY - 2021/5
Y1 - 2021/5
N2 - Malaria remains a major cause of mortality in the world and an efficient vaccine is the best chance of reducing the disease burden. Vaccination strategies for the liver stage of disease that utilise injection of live radiation-attenuated sporozoites (RAS) confer sterile immunity, which is mediated by CD8+ memory T cells, with liver-resident memory T cells (TRM) being particularly important. We have previously described a TCR transgenic mouse, termed PbT-I, where all CD8+ T cells recognize a specific peptide from Plasmodium. PbT-I form liver TRM cells upon RAS injection and are capable of protecting mice against challenge infection. Here, we utilize this transgenic system to examine whether nonliving sporozoites, killed by heat treatment (HKS), could trigger the development of Plasmodium-specific liver TRM cells. We found that HKS vaccination induced the formation of memory CD8+ T cells in the spleen and liver, and importantly, liver TRM cells were fewer in number than that induced by RAS. Crucially, we showed the number of TRM cells was significantly higher when HKS were combined with the glycolipid α-galactosylceramide as an adjuvant. In the future, this work could lead to development of an antimalaria vaccination strategy that does not require live sporozoites, providing greater utility.
AB - Malaria remains a major cause of mortality in the world and an efficient vaccine is the best chance of reducing the disease burden. Vaccination strategies for the liver stage of disease that utilise injection of live radiation-attenuated sporozoites (RAS) confer sterile immunity, which is mediated by CD8+ memory T cells, with liver-resident memory T cells (TRM) being particularly important. We have previously described a TCR transgenic mouse, termed PbT-I, where all CD8+ T cells recognize a specific peptide from Plasmodium. PbT-I form liver TRM cells upon RAS injection and are capable of protecting mice against challenge infection. Here, we utilize this transgenic system to examine whether nonliving sporozoites, killed by heat treatment (HKS), could trigger the development of Plasmodium-specific liver TRM cells. We found that HKS vaccination induced the formation of memory CD8+ T cells in the spleen and liver, and importantly, liver TRM cells were fewer in number than that induced by RAS. Crucially, we showed the number of TRM cells was significantly higher when HKS were combined with the glycolipid α-galactosylceramide as an adjuvant. In the future, this work could lead to development of an antimalaria vaccination strategy that does not require live sporozoites, providing greater utility.
KW - CD8 T cells
KW - Liver
KW - Plasmodium
KW - Sporozoites
KW - Vaccination
UR - http://www.scopus.com/inward/record.url?scp=85100988997&partnerID=8YFLogxK
U2 - 10.1002/eji.202048757
DO - 10.1002/eji.202048757
M3 - Article
SN - 0014-2980
VL - 51
SP - 1153
EP - 1165
JO - European Journal of Immunology
JF - European Journal of Immunology
IS - 5
ER -